FDA刚刚拒绝了Allergan的女性健康药物(AGN)


FDA刚刚拒绝了Allergan的女性健康药物(AGN)

Allergan周二表示,美国食品和药物管理局不会批准其中一种女性健康药物Esmya。

该药正在研究治疗子宫肌瘤,这是一种以子宫内和周围生长的良性肿瘤为特征的病症,可导致大量出血和疼痛。

Markets Insider

https://markets.businessinsider.com/news/stocks/allergan-stock-price-after-fda-esmya-uterine-fibroids-rejection-2018-8-1027477259

Allergan Falls on FDA’s Rejection of Uterine Fibroids Drug – August 22, 2018 – Zacks.com

https://www.zacks.com/stock/news/319081/allergan-falls-on-fdas-rejection-of-uterine-fibroids-drug?cid=CS-ZC-FT-319081